CEFUROXIME FOR INJECTION, USP POWDER FOR SOLUTION

Land: Canada

Språk: engelsk

Kilde: Health Canada

Kjøp det nå

Preparatomtale Preparatomtale (SPC)
28-08-2020

Aktiv ingrediens:

CEFUROXIME (CEFUROXIME SODIUM)

Tilgjengelig fra:

STERIMAX INC

ATC-kode:

J01DC02

INN (International Name):

CEFUROXIME

Dosering :

7.5G

Legemiddelform:

POWDER FOR SOLUTION

Sammensetning:

CEFUROXIME (CEFUROXIME SODIUM) 7.5G

Administreringsrute:

INTRAVENOUS

Enheter i pakken:

100ML

Resept typen:

Prescription

Terapeutisk område:

SECOND GENERATION CEPHALOSPORINS

Produkt oppsummering:

Active ingredient group (AIG) number: 0122448009; AHFS:

Autorisasjon status:

APPROVED

Autorisasjon dato:

2014-03-07

Preparatomtale

                                _ _
Cefuroxime for Injection, USP: Product Monograph_ _
Page 1 of 33
PRODUCT MONOGRAPH
PR
CEFUROXIME FOR INJECTION, USP
750 mg / 10 mL vial
1.5 g / 20 mL vial
7.5 g / 100 mL Pharmacy Bulk Vial
ANTIBIOTIC
SteriMax Inc.
2770 Portland Drive
Oakville, ON
L6H 6R4
Date of Revision:
August 28, 2020
Control No: 242254
_ _
Cefuroxime for Injection, USP - Product Monograph_ _
Page 2 of 33
PRODUCT MONOGRAPH
PR
CEFUROXIME FOR INJECTION, USP
750 mg / 10 mL vial
1.5 g / 20 mL vial
7.5 g / 100 mL Pharmacy Bulk Vial
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION AND CLINICAL PHARMACOLOGY
_In vitro _studies demonstrate that the bactericidal action of
cefuroxime results from inhibition of
bacterial cell wall synthesis by inhibiting the transpeptidase and
carboxypeptidase enzymes.
INDICATIONS AND CLINICAL USES
TREATMENT
Cefuroxime for Injection, USP may be indicated for the treatment of
patients with infections
caused by susceptible strains of the designated organisms in the
following diseases:
LOWER RESPIRATORY TRACT INFECTIONS:
Pneumonia caused by _Streptococcus pneumoniae, Haemophilus influenzae
_including ampicillin-
resistant strains, _Klebsiella _species, _Staphylococcus aureus
_including ampicillin-resistant (but not
methicillin-resistant) strains, _Streptococcus pyogenes_, and
_Escherichia coli. _
_ _
URINARY TRACT INFECTIONS:
Caused by _Escherichia coli_, and _Klebsiella _species.
SOFT TISSUE INFECTIONS:
Caused by _Staphylococcus aureus, _including ampicillin-resistant (but
not methicillin-resistant)
strains, _Streptococcus pyogenes, Escherichia coli_, and _Klebsiella
_species.
MENINGITIS:
Caused by _Staphylococcus aureus _including ampicillin-resistant (but
not methicillin-resistant)
strains, _Streptococcus pneumoniae, Haemophilus influenzae_, and
_Neisseria meningitidis_.
_ _
Cefuroxime for Injection, USP: Product Monograph_ _
Page 3 of 33
GONORRHEA:
Caused by _Neisseria gonorrhoeae _including ampicillin-resistant
strains.
BONE AND JOINT INFECTIONS:
Caused by _Staphylococcus aureus _(penicillinase and non-penicillinase
pro
                                
                                Les hele dokumentet
                                
                            

Dokumenter på andre språk

Preparatomtale Preparatomtale fransk 28-08-2020

Søk varsler relatert til dette produktet